Iaso Therapeutics, Inc.
Biotechnology company · East Lansing, Michigan, United States
Iaso Therapeutics, Inc. is a biotechnology company headquartered in East Lansing, Michigan, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $894,562 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $570,000 sold in a notice filed in 2026.
Iaso Therapeutics at a glance
What does Iaso Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $894,562 in total (2020 to 2021). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $570,000 sold (2026).
Frequently asked questions about Iaso Therapeutics
Where is Iaso Therapeutics headquartered?
Iaso Therapeutics, Inc. is headquartered in East Lansing, Michigan, United States.
What does Iaso Therapeutics do?
Iaso Therapeutics, Inc. is a biotechnology company.
When was Iaso Therapeutics founded?
The earliest incorporation on record for Iaso Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Tarn Biosciences, Inc.East Lansing, Michigan, United States
- Fibrosix Inc.East Lansing, Michigan, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences